China's Sinovac Biotech Ltd launched a late-stage human trial on Tuesday that will involve as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.
JAKARTA/BEIJING - China’s Sinovac Biotech Ltd launched a late-stage human trial on Tuesday that will involve as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.
The candidate, known as CoronaVac, is among a few potential vaccines that have entered late-stage trials for a large-scale study to gather proof of efficacy for regulatory approval. “The threat of COVID-19 will not subside until a vaccine is given to all the people,” said Indonesian President Joko Widodo at a ceremony to launch the trial in Bandung, West Java. “Hopefully in January, we can produce and vaccinate everyone in the country.”
Mid-stage trials usually test a candidate’s safety and ability to trigger an immune response in a relatively small number of people before it enters late-stage tests.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Sinovac launches late-stage trial for potential COVID-19 vaccine in IndonesiaChina's Sinovac Biotech Ltd launched on Tuesday a late-stage human trial involving as many as 1,620 patients in Indonesia for a COVID-19 vaccine candidate that it is developing with Indonesian state-owned peer Bio Farma.
Weiterlesen »
China's Sinopharm starts Phase III trial of COVID-19 vaccine in BahrainChinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in Bahrain, after launching similar trials in the United Arab Emirates last month, Bahrain's health ministry said on Monday.
Weiterlesen »
Indonesia reports 1,687 new coronavirus cases, 42 more deathsIndonesia reported 1,687 new coronavirus cases on Monday, bringing its total to 127,083, data from government's COVID-19 task force showed.
Weiterlesen »
Saudi Arabia to begin human trials with CanSino's Covid-19 vaccineResearchers say CanSino's vaccine which is co-developed with China's military research unit, appears to be safe and induced immune responses in most subjects.
Weiterlesen »
Goldman Sachs lifts 2021 US GDP forecast to 6.2% and predicts a COVID-19 vaccine will be 'widely distributed' by mid-2021 | Markets InsiderGoldman Sachs raised its 2021 US GDP forecast to 6.2% from 5.6%, driven by expectations that at least one COVID-19 vaccine will be 'widely distr...
Weiterlesen »
A letter from Chennai as India tops 2 million COVID-19 cases: ‘In the midst of so much death, despair and depression, life does go on’India has topped 2 million COVID-19 cases. Our report from Chennai, India shows the lockdown in March and the economic impact have hit the poorest Indians the hardest. 'In the midst of so much death, despair and depression, life does go on.'
Weiterlesen »